There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests

There may not be a safe off-ramp for some taking GLP-1 drugs, study suggests

Of the 308 who gained from tirzepatide, 254 (82 percent) restored a minimum of 25 percent of the weight they had actually lost on the drug by week 88. Even…

Read More »